GGrantIndex
← Leaderboards

Jon Clardy

Cornell University Ithaca

Google Scholar ↗PubMed ↗ORCID ↗
$25,367,659
Attributed
$28,369,562
Total exposure
24
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.9M · FY2005–21
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$32,728,830 · 25

By mechanism

R01$13,685,702 · 5
U19$12,419,629 · 7
U01$3,326,430 · 1
U54$1,651,820 · 1
R21$719,500 · 3
P41$713,508 · 6

Top collaborators

Others in their field

Top investigators on “Base”

Research focus

BaseSmall MoleculeBacteriaTherapeutic AgentsProgramsPathway InteractionsLaboratoriesProductionPlaySourceAntibioticsMicrobialScreening ProcedureGeneticBioinformaticsLeadBiologicalMemberPharmaceutical PreparationsGenomeBiological FactorsScreeningPathogenHigh Throughput Screening

Grant awards (98)

Identification and characterization of gut microbial bioactive molecules that determine predisposition to autoimmune disease and atopy$253,500
R01 · FY2021 · AT · contact PI
Identification and characterization of gut microbial bioactive molecules that determine predisposition to autoimmune disease and atopy$669,124
R01 · FY2020 · AT · contact PI
Identification and characterization of gut microbial bioactive molecules that determine predisposition to autoimmune disease and atopy$669,124
R01 · FY2019 · AT · contact PI
Chemical biology of bacterial symbionts$415,514
R01 · FY2019 · AT · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$798,694
U19 · FY2018 · TW · contact PI
Identification and characterization of gut microbial bioactive molecules that determine predisposition to autoimmune disease and atopy$669,124
R01 · FY2018 · AT · contact PI
Identification of novel secondary metabolites produced by symbiotic Proteobacte$475,202
U19 · FY2018 · AI · contact PI
Chemical biology of bacterial symbionts$415,514
R01 · FY2018 · AT · contact PI
Identification and characterization of gut microbial bioactive molecules that determine predisposition to autoimmune disease and atopy$339,137
R01 · FY2018 · AT · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$150,000
U19 · FY2018 · TW · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$102,114
U19 · FY2018 · TW · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$819,421
U19 · FY2017 · TW · contact PI
Identification and characterization of gut microbial bioactive molecules that determine predisposition to autoimmune disease and atopy$686,499
R01 · FY2017 · AT · contact PI
Identification of novel secondary metabolites produced by symbiotic Proteobacte$475,202
U19 · FY2017 · AI · contact PI
Chemical biology of bacterial symbionts$415,377
R01 · FY2017 · AT · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$102,114
U19 · FY2017 · TW · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$831,606
U19 · FY2016 · TW · contact PI
Identification of novel secondary metabolites produced by symbiotic Proteobacte$475,202
U19 · FY2016 · AI · contact PI
Chemical biology of bacterial symbionts$415,317
R01 · FY2016 · GM · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$102,114
U19 · FY2016 · TW · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$852,523
U19 · FY2015 · TW · contact PI
Identification of novel secondary metabolites produced by symbiotic Proteobacte$649,768
U19 · FY2015 · AI · contact PI
Chemical biology of bacterial symbionts$415,317
R01 · FY2015 · GM · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$64,614
U19 · FY2015 · TW · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$907,024
U19 · FY2014 · TW · contact PI
^Identification of novel secondary metabolites produced by symbiotic Proteobacte$641,924
U19 · FY2014 · AI · contact PI
Chemical biology of bacterial symbionts$415,317
R01 · FY2014 · GM · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$23,301
U19 · FY2014 · TW · contact PI
Chemical biology of bacterial symbionts$409,545
R01 · FY2013 · GM · contact PI
Genomic approaches of discovery broad-spectrum antimicrobial agents$265,455
U54 · FY2013 · AI · contact PI
Genomic approaches of discovery broad-spectrum antimicrobial agents$301,158
U54 · FY2012 · AI · contact PI
Molecule-to-gene approaches to new natural products$415,318
R01 · FY2011 · GM · contact PI
Genomic approaches of discovery broad-spectrum antimicrobial agents$362,764
U54 · FY2011 · AI · contact PI
Molecule-to-gene approaches to new natural products$419,513
R01 · FY2010 · GM · contact PI
Genomic approaches of discovery broad-spectrum antimicrobial agents$380,360
U54 · FY2010 · AI · contact PI
Target-Based High-Throughput Screens for Plasmodium falciparum Malaria$42,375
R21 · FY2010 · NS · contact PI
Fungi and Environmental DNA$593,482
U19 · FY2009 · CA · contact PI
Molecule-to-gene approaches to new natural products$416,800
R01 · FY2009 · GM · contact PI
Core--Small molecule screening and medicinal chemistry$372,521
U19 · FY2009 · AI · contact PI
Genomic approaches of discovery broad-spectrum antimicrobial agents$342,083
U54 · FY2009 · AI · contact PI
Applications of Natural Products to Chemical Biology$336,164
R01 · FY2009 · CA · contact PI
Core 3 - High Throughput Screening & Combinatorial Analyses Core$47,908
U19 · FY2009 · CA · contact PI
STRUCTURAL AND MECHANISTIC STUDIES OF THE PANTOCIN A BIOSYNTHESIS$21,416
P41 · FY2009 · RR · contact PI
Discovery of natural product-based drugs from Costa Rica$819,851
U01 · FY2008 · TW · contact PI
Fungi and Environmental DNA$610,585
U19 · FY2008 · CA · contact PI
Molecule-to-gene approaches to new natural products$405,438
R01 · FY2008 · GM · contact PI
Core--Small molecule screening and medicinal chemistry$372,523
U19 · FY2008 · AI · contact PI
Applications of Natural Products to Chemical Biology$336,164
R01 · FY2008 · CA · contact PI
Molecule-to-gene approaches to new natural products$254,000
R01 · FY2008 · GM · contact PI
Core 3 - High Throughput Screening & Combinatorial Analyses Core$81,074
U19 · FY2008 · CA · contact PI
Discovery of natural product-based drugs from Costa Rica$819,851
U01 · FY2007 · TW · contact PI
Fungi and Environmental DNA$614,470
U19 · FY2007 · CA · contact PI
Core--Small molecule screening and medicinal chemistry$381,781
U19 · FY2007 · AI · contact PI
Applications of Natural Products to Chemical Biology$336,164
R01 · FY2007 · CA · contact PI
Structural and Functional Studies on Proteins$289,290
R01 · FY2007 · CA · contact PI
Core 3 - High Throughput Screening & Combinatorial Analyses Core$120,474
U19 · FY2007 · CA · contact PI
Target-Based High-Throughput Screens for Plasmodium falciparum Malaria$84,500
R21 · FY2007 · NS · contact PI
Discovery of natural product-based drugs from Costa Ric*$826,974
U01 · FY2006 · TW · contact PI
Fungi and Environmental DNA$499,803
U19 · FY2006 · CA · contact PI
Core--Small molecule screening and medicinal chemistry$348,072
U19 · FY2006 · AI · contact PI
Applications of Natural Products to Chemical Biology$346,204
R01 · FY2006 · CA · contact PI
Structural and Functional Studies on Proteins$297,930
R01 · FY2006 · CA · contact PI
Core 3 - High Throughput Screening & Combinatorial Analyses Core$53,055
U19 · FY2006 · CA · contact PI
Discovery of natural product-based drugs from Costa Rica$859,754
U01 · FY2005 · TW
Fungi and Environmental DNA$505,687
U19 · FY2005 · CA
Applications of Natural Products to Chemical Biology$377,138
R01 · FY2005 · CA
Core--Small molecule screening and medicinal chemistry$347,371
U19 · FY2005 · AI
Structural and Functional Studies on Proteins$305,100
R01 · FY2005 · CA
Phenotypic-based high throughput screens-Plasmodium(RMI)$211,875
R21 · FY2005 · NS
STRUCTURAL AND ENZYMATIC CHARACTERIZATION OF FEEM, AN N-ACYL TRANSFERASE$6,135
P41 · FY2005 · RR
Applications of Natural Products to Chemical Biology$375,746
R01 · FY2004 · CA
Structural and Functional Studies on Proteins$326,475
R01 · FY2004 · CA
Potential Drugs from Poorly Understood Costa Rican Biota$200,750
R21 · FY2004 · TW
High-throughput Screens for P. falciparum Malaria (RMI)$84,750
R03 · FY2004 · NS
STRUCTURAL AND ENZYMATIC CHARACTERIZATION OF FEEM$23,969
P41 · FY2004 · RR
SMALL MOLECULES: STRUCTURE OF INTERACTIVE PROTEINS$5,572
P41 · FY2004 · RR
Applications of Natural Products to Chemical Biology$373,800
R01 · FY2003 · CA
STRUCTURAL STUDIES OF IMMUNOPHILINS AND RELATED PROTEINS$244,677
R01 · FY2003 · CA
Potential Drugs from Poorly Understood Costa Rican Biota$180,000
R21 · FY2003 · TW
Applications of Natural Products to Chemical Biology$314,438
R01 · FY2002 · CA
STRUCTURAL STUDIES OF IMMUNOPHILINS AND RELATED PROTEINS$224,047
R01 · FY2002 · CA
MACCHESS CONSORTIUM FOR PHASING METHODS IN MACROMOLECULAR CRYSTALLOGRAPHY$142,703
P41 · FY2002 · RR
NATURAL PRODUCT STRUCTURE &THEIR MACROMOLECULAR TARGETS: GENE THERAPY$142,703
P41 · FY2002 · RR
POTENTIALLY USEFUL ANTICANCER COMPONENTS FROM FUNGI$0
U19 · FY2002 · CA
APPLICATIONS OF NATURAL PRODUCTS TO CHEMICAL BIOLOGY$320,765
R01 · FY2001 · CA
STRUCTURAL STUDIES OF IMMUNOPHILINS AND RELATED PROTEINS$233,071
R01 · FY2001 · CA
NATURAL PRODUCT STRUCTURE &THEIR MACROMOLECULAR TARGETS: GENE THERAPY$142,703
P41 · FY2001 · RR
MACCHESS CONSORTIUM FOR PHASING METHODS IN MACROMOLECULAR CRYSTALLOGRAPHY$142,703
P41 · FY2001 · RR
STRUCTURE DETERMINATION OF KEY PROTEINS IN IMMUNOSUPPRESSIVE PATHWAY$120,630
U41 · FY2001 · RR
CONTROL OF CELLULAR PROCESSES BY RAPAMYCIN &ITS ANALOGS: IMMUNOSUPPRESSION, HIV$12,855
P41 · FY2001 · RR
POTENTIALLY USEFUL ANTICANCER COMPONENTS FROM FUNGI$0
U19 · FY2001 · CA
APPLICATIONS OF NATURAL PRODUCTS TO CHEMICAL BIOLOGY$314,367
R01 · FY2000 · CA
STRUCTURAL STUDIES OF IMMUNOPHILINS AND RELATED PROTEINS$234,684
R01 · FY2000 · CA
MACCHESS CONSORTIUM FOR PHASING METHODS IN MACROMOLECULAR CRYSTALLOGRAPHY$44,917
P41 · FY2000 · RR
CONTROL OF CELLULAR PROCESSES BY RAPAMYCIN &ITS ANALOGS: IMMUNOSUPPRESSION, HIV$24,318
P41 · FY2000 · RR
STRUCTURE DETERMINATION OF KEY PROTEINS IN IMMUNOSUPPRESSIVE PATHWAY$6,861
U41 · FY2000 · RR
NATURAL PRODUCT STRUCTURE &THEIR MACROMOLECULAR TARGETS: GENE THERAPY$3,514
P41 · FY2000 · RR
POTENTIALLY USEFUL ANTICANCER COMPONENTS FROM FUNGI$0
U19 · FY2000 · CA